Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of BAY987517 Gel Sunscreen in Controlled Use Conditions
NCT03012347Completed
- Sponsor
- Bayer
- Start
- Jan 2017
- Primary completion
- Jan 2017
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of BAY987517 in sunburn, sponsored by Bayer. Primary endpoint: Feeling of discomfort after product application at 15 minutes. Started Jan 2017; status: completed.
02
Drugs
BAY987517
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT03012347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03012347.